Spotlight on GOT2 in Cancer Metabolism

SA Kerk, J Garcia-Bermudez, K Birsoy… - OncoTargets and …, 2023 - Taylor & Francis
GOT2 is at the nexus of several critical metabolic pathways in homeostatic cellular and
dysregulated cancer metabolism. Despite this, recent work has emphasized the remarkable …

[HTML][HTML] PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia

CB Machado, EL da Silva, WAS Ferreira… - Cancers, 2023 - mdpi.com
Simple Summary Acute lymphoblastic leukemia (ALL) is the most common childhood cancer
and the presence of BCR:: ABL1 fusion in p190 isoform is a marker for worse prognosis …

[HTML][HTML] GLS and GOT2 as prognostic biomarkers associated with dendritic cell and immunotherapy response in breast cancer

R Yang, S Cheng, J Xiao, Y Pei, Z Zhu, J Zhang, J Feng… - Heliyon, 2024 - cell.com
Breast cancer is the females' most common cancer. Targeting the immune microenvironment
is a new and promising treatment method for breast cancer. Nevertheless, only a small …

[HTML][HTML] Molecules at Play in Cancer

DA Iacobas - Current Issues in Molecular Biology, 2023 - mdpi.com
Despite its wide range of incidence, cancer can spontaneously occur in any part of the body
and invade regions other than the originally affected tissue. Extensive research conducted …

[HTML][HTML] Pan-cancer molecular signatures connecting aspartate transaminase (AST) to cancer prognosis, metabolic and immune signatures

GH Siwo, AG Singal, AK Waljee - bioRxiv, 2024 - ncbi.nlm.nih.gov
Background Serum aspartate transaminase (sAST) level is used routinely in conjunction
with other clinical assays to assess liver health and disease. Increasing evidence suggests …

Evaluation of aristolochic acid Ι nephrotoxicity in mice via 1H NMR quantitative metabolomics and network pharmacology approaches

LL Feng, Z Huang, YY Nong, BJ Guo… - Toxicology …, 2023 - academic.oup.com
Background Although many studies have shown that herbs containing aristolochic acids can
treat various human diseases, AAΙ in particular has been implicated as a nephrotoxic agent …

[HTML][HTML] PARP1 is differentially expressed in BCR-ABL p190+ ALL patient samples and targeting PARP inhibition induces cell death comparable to that of tyrosine …

CB Machado, WAS Ferreira, F Pessoa… - … , Transfusion and Cell …, 2023 - Elsevier
Objective BCR-ABL1 p190 translocation represents a worse prognosis for acute
lymphoblastic leukemia (ALL) patients, and development of new therapeutic approaches is …